NTRA
insider transactionsNatera, Inc. — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
Net shares · 30d
-286.4K
0 buy · 286.4K sell
Net value · 30d
-$70.2M
$0 in · $70.2M out
Sentiment · 30d
Net selling
0% buying · 100% selling
Open-market trades · 30d
61
0 buy · 286.4K sell
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Sell·S
Director · 10b5-1
$642.5K
3.0K sh · $216.78
Own -49%
-
Grant·A
Director
$0
4.6K sh
Own +15%
-
Sell·S
EXECUTIVE CHAIRMAN · 10b5-1
$87.5K
400 sh · $218.72
Own -0%
-
Sell·S
EXECUTIVE CHAIRMAN · 10b5-1
$829.3K
3.8K sh · $217.60
Own -0%
-
Sell·S
EXECUTIVE CHAIRMAN · 10b5-1
$1.5M
6.7K sh · $216.81
Own -0%
-
Sell·S
EXECUTIVE CHAIRMAN · 10b5-1
$2.6M
11.9K sh · $215.91
Own -1%
-
Sell·S
EXECUTIVE CHAIRMAN · 10b5-1
$2.2M
10.3K sh · $214.72
Own -0%
-
Sell·S
EXECUTIVE CHAIRMAN · 10b5-1
$1.7M
7.8K sh · $213.88
Own -0%
-
Sell·S
EXECUTIVE CHAIRMAN · 10b5-1
$1.1M
5.1K sh · $212.84
Own -0%
-
Sell·S
EXECUTIVE CHAIRMAN · 10b5-1
$262.0K
1.2K sh · $211.81
Own -0%
-
Sell·S
EXECUTIVE CHAIRMAN · 10b5-1
$386.1K
1.8K sh · $210.73
Own -0%
-
Sell·S
EXECUTIVE CHAIRMAN · 10b5-1
$174.4K
831 sh · $209.83
Own -0%
-
Sell·S
Director · 10b5-1
$64.1K
300 sh · $213.54
Own -0%
-
Sell·S
Director · 10b5-1
$106.2K
500 sh · $212.42
Own -0%
-
Sell·S
Director · 10b5-1
$126.8K
600 sh · $211.34
Own -0%
-
Sell·S
Director · 10b5-1
$368.0K
1.8K sh · $210.29
Own -1%
-
Sell·S
EXECUTIVE CHAIRMAN · 10b5-1
$352.1K
1.6K sh · $219.36
Own -0%
-
Sell·S
EXECUTIVE CHAIRMAN · 10b5-1
$465.4K
2.1K sh · $218.17
Own -0%
-
Sell·S
EXECUTIVE CHAIRMAN · 10b5-1
$929.3K
4.3K sh · $217.32
Own -0%
-
Sell·S
EXECUTIVE CHAIRMAN · 10b5-1
$1.6M
7.2K sh · $216.51
Own -0%
-
Sell·S
EXECUTIVE CHAIRMAN · 10b5-1
$680.8K
3.2K sh · $215.38
Own -0%
-
Sell·S
EXECUTIVE CHAIRMAN · 10b5-1
$1.2M
5.7K sh · $214.35
Own -0%
-
Sell·S
EXECUTIVE CHAIRMAN · 10b5-1
$1.1M
5.0K sh · $213.43
Own -0%
-
Sell·S
EXECUTIVE CHAIRMAN · 10b5-1
$2.6M
12.1K sh · $212.27
Own -1%
-
Sell·S
EXECUTIVE CHAIRMAN · 10b5-1
$625.7K
3.0K sh · $211.61
Own -0%
-
Sell·S
EXECUTIVE CHAIRMAN · 10b5-1
$687.0K
3.3K sh · $210.30
Own -0%
-
Sell·S
EXECUTIVE CHAIRMAN · 10b5-1
$531.3K
2.5K sh · $209.50
Own -0%
-
Exercise·M
Director
$0
11.0K sh
Own New
-
Sell·S
Director
$25.4K
116 sh · $218.82
Own -2%
-
Sell·S
Director
$692.3K
3.2K sh · $218.11
Own -34%
-
Sell·S
Director
$1.0M
4.7K sh · $217.30
Own -33%
-
Sell·S
Director
$651.6K
3.0K sh · $216.06
Own -18%
-
Exercise·M
Director
$251.1K
11.0K sh · $22.83
Own +178%
-
Sell·S
CEO AND PRESIDENT · 10b5-1
$773.7K
3.4K sh · $226.97
Own -3%
-
Sell·S
CEO AND PRESIDENT · 10b5-1
$1.5M
6.8K sh · $226.15
Own -6%
-
Sell·S
CEO AND PRESIDENT · 10b5-1
$366.7K
1.6K sh · $224.99
Own -1%
-
Sell·S
CEO AND PRESIDENT · 10b5-1
$323.1K
1.4K sh · $223.91
Own -1%
-
Sell·S
CEO AND PRESIDENT · 10b5-1
$1.5M
6.5K sh · $223.34
Own -5%
-
Sell·S
CEO AND PRESIDENT · 10b5-1
$445.8K
2.0K sh · $222.25
Own -2%
-
Sell·S
CEO AND PRESIDENT · 10b5-1
$528.5K
2.4K sh · $220.19
Own -2%
-
Sell·S
CEO AND PRESIDENT · 10b5-1
$604.2K
2.8K sh · $219.08
Own -2%
-
Sell·S
CEO AND PRESIDENT · 10b5-1
$380.3K
1.7K sh · $218.28
Own -1%
-
Sell·S
CEO AND PRESIDENT · 10b5-1
$510.3K
2.4K sh · $217.04
Own -2%
-
Sell·S
CEO AND PRESIDENT · 10b5-1
$1.2M
5.5K sh · $216.13
Own -4%
-
Sell·S
CEO AND PRESIDENT · 10b5-1
$279.3K
1.3K sh · $214.83
Own -1%
-
Sell·S
CEO AND PRESIDENT · 10b5-1
$534.3K
2.5K sh · $213.44
Own -2%
-
Sell·S
CEO AND PRESIDENT · 10b5-1
$176.7K
832 sh · $212.42
Own -1%
-
Sell·S
Director
$159.9K
400 sh · $399.82
Own -0%
-
Sell·S
Director
$3.9M
9.9K sh · $398.74
Own -6%
-
Sell·S
Director
$11.5M
28.9K sh · $397.99
Own -15%
-
Sell·S
Director
$1.7M
4.2K sh · $397.25
Own -2%
-
Sell·S
Director
$268.9K
680 sh · $395.48
Own -0%
-
Sell·S
PRESIDENT, CLINICALDIAGNOSTICS · 10b5-1
$126.2K
572 sh · $220.67
Own -0%
-
Sell·S
PRESIDENT, CLINICALDIAGNOSTICS · 10b5-1
$46.7K
213 sh · $219.34
Own -0%
-
Sell·S
PRESIDENT, CLINICALDIAGNOSTICS · 10b5-1
$90.4K
413 sh · $218.84
Own -0%
-
Sell·S
PRESIDENT, CLINICALDIAGNOSTICS · 10b5-1
$392.0K
1.8K sh · $217.52
Own -1%
-
Sell·S
Director
$548.4K
2.5K sh · $223.83
Own -0%
-
Sell·S
Director
$635.0K
2.9K sh · $222.79
Own -0%
-
Sell·S
Director
$3.3M
14.9K sh · $221.58
Own -1%
-
Sell·S
Director
$4.7M
21.3K sh · $220.94
Own -2%
-
Sell·S
Director
$2.2M
10.1K sh · $219.78
Own -1%
-
Sell·S
Director
$5.8M
26.4K sh · $218.69
Own -2%
-
Grant·A
Director
—
2.1K sh
Own +42480%
-
Sell·S
PRESIDENT, CLINICALDIAGNOSTICS · 10b5-1
$335.1K
1.7K sh · $202.84
Own -1%
-
Sell·S
John Fesko KEY
PRESIDENT, CHIEF BUS. OFFICER · 10b5-1
$291.7K
1.4K sh · $202.84
Own -1%
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Jun 16, 2026 | Rowan E Chapman 10b5-1 | Sell S | 3.0K | $642.5K |
| Jun 16, 2026 | Roelof Botha | Grant A | 4.6K | $0 |
| Jun 15, 2026 | Matthew Rabinowitz KEY 10b5-1 | Sell S | 400 | $87.5K |
| Jun 15, 2026 | Matthew Rabinowitz KEY 10b5-1 | Sell S | 3.8K | $829.3K |
| Jun 15, 2026 | Matthew Rabinowitz KEY 10b5-1 | Sell S | 6.7K | $1.5M |
| Jun 15, 2026 | Matthew Rabinowitz KEY 10b5-1 | Sell S | 11.9K | $2.6M |
| Jun 15, 2026 | Matthew Rabinowitz KEY 10b5-1 | Sell S | 10.3K | $2.2M |
| Jun 15, 2026 | Matthew Rabinowitz KEY 10b5-1 | Sell S | 7.8K | $1.7M |
| Jun 15, 2026 | Matthew Rabinowitz KEY 10b5-1 | Sell S | 5.1K | $1.1M |
| Jun 15, 2026 | Matthew Rabinowitz KEY 10b5-1 | Sell S | 1.2K | $262.0K |
| Jun 15, 2026 | Matthew Rabinowitz KEY 10b5-1 | Sell S | 1.8K | $386.1K |
| Jun 15, 2026 | Matthew Rabinowitz KEY 10b5-1 | Sell S | 831 | $174.4K |
| Jun 15, 2026 | Jonathan Sheena 10b5-1 | Sell S | 300 | $64.1K |
| Jun 15, 2026 | Jonathan Sheena 10b5-1 | Sell S | 500 | $106.2K |
| Jun 15, 2026 | Jonathan Sheena 10b5-1 | Sell S | 600 | $126.8K |
| Jun 15, 2026 | Jonathan Sheena 10b5-1 | Sell S | 1.8K | $368.0K |
| Jun 12, 2026 | Matthew Rabinowitz KEY 10b5-1 | Sell S | 1.6K | $352.1K |
| Jun 12, 2026 | Matthew Rabinowitz KEY 10b5-1 | Sell S | 2.1K | $465.4K |
| Jun 12, 2026 | Matthew Rabinowitz KEY 10b5-1 | Sell S | 4.3K | $929.3K |
| Jun 12, 2026 | Matthew Rabinowitz KEY 10b5-1 | Sell S | 7.2K | $1.6M |
| Jun 12, 2026 | Matthew Rabinowitz KEY 10b5-1 | Sell S | 3.2K | $680.8K |
| Jun 12, 2026 | Matthew Rabinowitz KEY 10b5-1 | Sell S | 5.7K | $1.2M |
| Jun 12, 2026 | Matthew Rabinowitz KEY 10b5-1 | Sell S | 5.0K | $1.1M |
| Jun 12, 2026 | Matthew Rabinowitz KEY 10b5-1 | Sell S | 12.1K | $2.6M |
| Jun 12, 2026 | Matthew Rabinowitz KEY 10b5-1 | Sell S | 3.0K | $625.7K |
| Jun 12, 2026 | Matthew Rabinowitz KEY 10b5-1 | Sell S | 3.3K | $687.0K |
| Jun 12, 2026 | Matthew Rabinowitz KEY 10b5-1 | Sell S | 2.5K | $531.3K |
| Jun 5, 2026 | Gail Boxer Marcus | Exercise M | 11.0K | $0 |
| Jun 5, 2026 | Gail Boxer Marcus | Sell S | 116 | $25.4K |
| Jun 5, 2026 | Gail Boxer Marcus | Sell S | 3.2K | $692.3K |
| Jun 5, 2026 | Gail Boxer Marcus | Sell S | 4.7K | $1.0M |
| Jun 5, 2026 | Gail Boxer Marcus | Sell S | 3.0K | $651.6K |
| Jun 5, 2026 | Gail Boxer Marcus | Exercise M | 11.0K | $251.1K |
| Jun 4, 2026 | Steven Leonard Chapman KEY 10b5-1 | Sell S | 3.4K | $773.7K |
| Jun 4, 2026 | Steven Leonard Chapman KEY 10b5-1 | Sell S | 6.8K | $1.5M |
| Jun 4, 2026 | Steven Leonard Chapman KEY 10b5-1 | Sell S | 1.6K | $366.7K |
| Jun 4, 2026 | Steven Leonard Chapman KEY 10b5-1 | Sell S | 1.4K | $323.1K |
| Jun 4, 2026 | Steven Leonard Chapman KEY 10b5-1 | Sell S | 6.5K | $1.5M |
| Jun 4, 2026 | Steven Leonard Chapman KEY 10b5-1 | Sell S | 2.0K | $445.8K |
| Jun 4, 2026 | Steven Leonard Chapman KEY 10b5-1 | Sell S | 2.4K | $528.5K |
| Jun 4, 2026 | Steven Leonard Chapman KEY 10b5-1 | Sell S | 2.8K | $604.2K |
| Jun 4, 2026 | Steven Leonard Chapman KEY 10b5-1 | Sell S | 1.7K | $380.3K |
| Jun 4, 2026 | Steven Leonard Chapman KEY 10b5-1 | Sell S | 2.4K | $510.3K |
| Jun 4, 2026 | Steven Leonard Chapman KEY 10b5-1 | Sell S | 5.5K | $1.2M |
| Jun 4, 2026 | Steven Leonard Chapman KEY 10b5-1 | Sell S | 1.3K | $279.3K |
| Jun 4, 2026 | Steven Leonard Chapman KEY 10b5-1 | Sell S | 2.5K | $534.3K |
| Jun 4, 2026 | Steven Leonard Chapman KEY 10b5-1 | Sell S | 832 | $176.7K |
| Jun 2, 2026 | Roelof Botha | Sell S | 400 | $159.9K |
| Jun 2, 2026 | Roelof Botha | Sell S | 9.9K | $3.9M |
| Jun 2, 2026 | Roelof Botha | Sell S | 28.9K | $11.5M |
| Jun 2, 2026 | Roelof Botha | Sell S | 4.2K | $1.7M |
| Jun 2, 2026 | Roelof Botha | Sell S | 680 | $268.9K |
| Jun 1, 2026 | Solomon Moshkevich KEY 10b5-1 | Sell S | 572 | $126.2K |
| Jun 1, 2026 | Solomon Moshkevich KEY 10b5-1 | Sell S | 213 | $46.7K |
| Jun 1, 2026 | Solomon Moshkevich KEY 10b5-1 | Sell S | 413 | $90.4K |
| Jun 1, 2026 | Solomon Moshkevich KEY 10b5-1 | Sell S | 1.8K | $392.0K |
| Jun 1, 2026 | Roelof Botha | Sell S | 2.5K | $548.4K |
| Jun 1, 2026 | Roelof Botha | Sell S | 2.9K | $635.0K |
| Jun 1, 2026 | Roelof Botha | Sell S | 14.9K | $3.3M |
| Jun 1, 2026 | Roelof Botha | Sell S | 21.3K | $4.7M |
| Jun 1, 2026 | Roelof Botha | Sell S | 10.1K | $2.2M |
| Jun 1, 2026 | Roelof Botha | Sell S | 26.4K | $5.8M |
| May 29, 2026 | Eric H Rubin | Grant A | 2.1K | — |
| May 26, 2026 | Solomon Moshkevich KEY 10b5-1 | Sell S | 1.7K | $335.1K |
| May 26, 2026 | John Fesko KEY 10b5-1 | Sell S | 1.4K | $291.7K |
About NTRA insider trading
This page tracks insider transactions for Natera, Inc. (NTRA) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.